UNSPSC 51181625: Calcitonin salmon

This classification denotes a peptide hormone with the molecular formula C145H240N44O48S2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 7SFC6U2VI5, chemically known as calcitonin (salmon) [ep], but more generally known as calcitonin salmon, which bears US NIH Compound Identifier 16129616. European Medicines Agency schedules calcitonin salmon or its base in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB00948MIG. Most nations, for tariff purposes, schedule calcitonin salmon under HS 29371900. SMILES:.

Calcitonin salmon bears US NLM identifiers UMLS ID C0073994 and NCI Concept Code C329.

UNSPSC 51181625 Calcitonin salmon, a Commodity code, covers pharmaceutical products for treatment and therapeutic use that state and local health agencies, correctional systems, and cooperative purchasing alliances acquire through multi-source generic and branded pharmaceutical procurement frameworks. Recent state and local solicitations under this code emphasize competitive pricing, FDA compliance, cGMP certification, Drug Supply Chain Security Act adherence, and distribution through established pharmaceutical wholesaler networks. Issuing bodies include state health departments and multistate cooperative purchasing alliances that aggregate demand across participating jurisdictions and facility types — hospitals, clinics, correctional institutions, and other government healthcare operations. The procurement structure typically requires vendors to maintain relationships with multiple authorized wholesalers, submit detailed product specifications including National Drug Codes and SKUs, demonstrate pricing flexibility through various net-price and WAC-minus structures, and carry comprehensive insurance including commercial general liability and network security coverage.

The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration's Office of State Procurement, issued a Request for Proposal on January 20, 2026 (S1070000015802) to establish multiple contracts for generic multi-source pharmaceuticals and OTC products serving participating state and local government facilities across Minnesota and Oregon, with proposals due March 26, 2026. The solicitation specifies three authorized wholesalers—AmerisourceBergen Drug Corporation (Cencora), Cardinal Health 110 and 112, and Morris & Dickson Co., LLC—and evaluates vendor responses on price competitiveness (75 percent weight), fixed pricing (10 percent), EDI capability (5 percent), compliance with administrative fee data format requirements (5 percent), and agreement to a 3 percent administrative fee (5 percent). Contract awards are scheduled to take effect July 1, 2026, with an initial two-year term for new responders and optional extensions at MMCAP's discretion. No specific set-aside designations are disclosed in available documentation.